ID: ALA5185350

Max Phase: Preclinical

Molecular Formula: C33H42O7

Molecular Weight: 550.69

Associated Items:

Representations

Canonical SMILES:  C#CCCC(=O)OCC1=C(C)CC([C@@H](C)[C@H]2CC[C@H]3[C@@H]4C[C@H]5O[C@]56[C@@H](O)C=CC(=O)[C@]6(C)[C@H]4CC[C@]23C)OC1=O

Standard InChI:  InChI=1S/C33H42O7/c1-6-7-8-29(36)38-17-21-18(2)15-25(39-30(21)37)19(3)22-9-10-23-20-16-28-33(40-28)27(35)12-11-26(34)32(33,5)24(20)13-14-31(22,23)4/h1,11-12,19-20,22-25,27-28,35H,7-10,13-17H2,2-5H3/t19-,20-,22+,23-,24-,25?,27-,28+,31+,32-,33+/m0/s1

Standard InChI Key:  IQYONSLHNBWXDH-ORIRKRBUSA-N

Associated Targets(Human)

IPO5 Tbio Importin-5 (9 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP90AA1 Tchem Heat shock protein HSP90 (3606 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Influenza A virus (11224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 550.69Molecular Weight (Monoisotopic): 550.2931AlogP: 4.32#Rotatable Bonds: 6
Polar Surface Area: 102.43Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.46CX Basic pKa: CX LogP: 4.81CX LogD: 4.81
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.30Np Likeness Score: 3.17

References

1. Patouret R, Barluenga S, Winssinger N..  (2022)  Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibitor of influenza A replication.,  69  [PMID:35772286] [10.1016/j.bmc.2022.116883]

Source